يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Gómez Seguí, Inés"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية

    مصطلحات موضوعية: Acute myeloid leukaemia, Cancer genomics, Risk factors

  2. 2
    دورية أكاديمية

    المساهمون: HUS Comprehensive Cancer Center, University Management, Helsinki University Hospital Area, Department of Oncology, Hematologian yksikkö

    وصف الملف: application/pdf

    العلاقة: This work was funded by Blood Cancer UK (to JMA; #06002 and #13044). The Hungarian AML study was funded by the Hungarian National Research, Development and Innovation Office (NKFIH) (NVKP_16-1-2016-0004), a Momentum grant (LP-95021) from the Hungarian Academy of Sciences and EU’s Horizon 2020 research and innovation program under grant agreement No. 739593. The KORA study was initiated and financed by the Helmholtz Zentrum München—German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universität, as part of LMUinnovativ. The recruitment of cases via the Catholic University of Rome was funded by Progetto AIRC 5permille Mynerva. DN is an endowed Professor of the Deutsche Jose Carreras Leukaemie Stiftung (DJCLS H 03/01) and is funded by the H.W. & J. Hector fund, Baden Wuerttemberg and the Dr. Rolf M. Schwiete Fund, Mannheim. MM is employed by the Munich Leukemia Laboratory and TH is part owner of the Munich Leukemia Laboratory. We are grateful to the Newcastle University Biobank (https://www.ncl.ac.uk/biobanksTest/) for providing samples. Collection of patient samples and associated clinico-pathological information was undertaken with written informed consent. All studies were conducted in accordance with the Declaration of Helsinki and received local institutional review board or national research ethics approval (Supplementary Table 9). Specifically, this research has been conducted using the UK Biobank Resource (Application #16583, James Allan). MRC/NCRI AML 11 trial, AML 12 trial and the UK Leukaemia Research Fund (LLR) population-based case–control study of adult acute leukemia received multicenter research ethics committee approval54,55,75. Research ethics committee approval was given to the Newcastle Haematology Biobank (07/H0906/109 + 5) and the AML genome-wide association study in the UK (06/q1108/92, BH136664 (7078)). AML cases and controls for Samples from the Hungarian AML patients were obtained during the standard diagnostic workup at the Hematology Divisions of the 1st and 3rd Department of Internal Medicine, Semmelweis University, Budapest, following ethical approval from the Local Ethical Committee (REF TUKEB-1552012) and the Hungarian Medical Research Council (REF 45371-2/2016/EKU). Saliva and fibroblast samples from Austrian AML patients were collected at the Division of Hematology, Medical University of Graz, Graz, Austria76. The diagnosis of AML was made in accordance with World Health Organisation guidelines.; Lin , W Y , Fordham , S E , Hungate , E , Sunter , N J , Elstob , C , Xu , Y , Park , C , Quante , A , Strauch , K , Gieger , C , Skol , A , Rahman , T , Sucheston-Campbell , L , Wang , J , Hahn , T , Clay-Gilmour , A I , Jones , G L , Marr , H J , Jackson , G H , Menne , T , Collin , M , Ivey , A , Hills , R K , Burnett , A K , Russell , N H , Fitzgibbon , J , Larson , R A , Le Beau , M M , Stock , W , Heidenreich , O , Alharbi , A , Allsup , D J , Houlston , R S , Norden , J , Dickinson , A M , Douglas , E , Lendrem , C , Daly , A K , Palm , L , Piechocki , K , Jeffries , S , Bornhäuser , M , Röllig , C , Altmann , H , Ruhnke , L , Kunadt , D , Wagenführ , L , Cordell , H J , Darlay , R , Andersen , M K , Fontana , M C , Martinelli , G , Marconi , G , Sanz , M A , Cervera , J , Gómez-Seguí , I , Cluzeau , T , Moreilhon , C , Raynaud , S , Sill , H , Voso , M T , Lo-Coco , F , Dombret , H , Cheok , M , Preudhomme , C , Gale , R E , Linch , D , Gaal-Wesinger , J , Masszi , A , Nowak , D , Hofmann , W K , Gilkes , A , Porkka , K , Milosevic Feenstra , J D , Kralovics , R , Grimwade , D , Meggendorfer , M , Haferlach , T , Krizsán , S , Bödör , C , Stölzel , F , Onel , K & Allan , J M 2021 , ' Genome-wide association study identifies susceptibility loci for acute myeloid leukemia ' , Nature Communications , vol. 12 , no. 1 , 6233 . https://doi.org/10.1038/s41467-021-26551-xTest; ORCID: /0000-0003-4112-5902/work/104212645; 85118442520; c5527ec5-ec3a-4404-8d63-1c21154fdd43; http://hdl.handle.net/10138/337099Test; 000712910500011

  3. 3
    دورية أكاديمية

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Institut de Pathologie CHU Lille, Pôle de Biologie Pathologie Génétique CHU Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-04541118; https://hal.science/hal-04541118Test

  4. 4
    دورية أكاديمية

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Institut de Pathologie CHU Lille, Pôle de Biologie Pathologie Génétique CHU Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-04541118; https://hal.science/hal-04541118Test

  5. 5

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 CANTHER, Institut de Pathologie CHU Lille

    وصف الملف: application/octet-stream

    العلاقة: Nature Communications; http://hdl.handle.net/20.500.12210/113017Test

  6. 6
    دورية أكاديمية

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Institut de Pathologie CHU Lille, Pôle de Biologie Pathologie Génétique CHU Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-04541402; https://hal.science/hal-04541402Test

  7. 7
    دورية أكاديمية

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Institut de Pathologie CHU Lille, Pôle de Biologie Pathologie Génétique CHU Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-04541402; https://hal.science/hal-04541402Test

  8. 8

    المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 CANTHER, Institut de Pathologie CHU Lille

    العلاقة: Nature Communications; http://hdl.handle.net/20.500.12210/113005Test